Bayer | BAYN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Air Liquide EUR 26.21B 1.7B 2025-12
Akzo Nobel EUR 4.88B 222M 2026-03
Alcon AG USD 22.13B 99M 2026-03
Amarin USD 449.41M 9.87M 2026-03
Arkema EUR 6.96B 913.9M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
BASF EUR 33.2B 434M 2025-12
Bayer EUR 28.85B 2.9B 2026-03
Beiersdorf EUR 8.6B 133M 2025-12
Corteva USD 24.36B 218M 2026-03
Covestro EUR 7B 908M 2025-12
Essilor EUR 38.89B 1.07B 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.85B 96M 2025-12
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Henkel EUR 20.5B 459M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Johnson Matthey GBP 2.02B 85M 2026-06
Linde USD 40.09B 1.85B 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Nutrien USD 25.15B 169M 2026-03
Philips EUR 11.39B 403M 2026-03
PPG Industries USD 8.1B 163M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
SAP EUR 44.86B 109M 2026-03
Solvay EUR 1.18B 161M 2026-03
UCB EUR 10.87B 1.18B 2025-12
Umicore EUR 2.24B 195.4M 2025-12
Vinci EUR 34.33B 5.71B 2025-12